Analyst consensus rating
Niagen Bioscience Analyst Rating: Strong Buy
NAGE is rated Strong Buy by 6 analysts with a $12.08 target. As of 2026-09-03.
Direct answer
Niagen Bioscience's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.08.
Forecast evidence checked September 3, 2026.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.17
- Average price target
- $12.08
- High price target
- $22.00
- Low price target
- $8.50
- Low target gap
- +168.1%
- Target upside
- +281.2%
- High target gap
- +594%
- Target range width
- 425.9%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- September 3, 2026
- Valid through
- September 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Niagen Bioscience?
Niagen Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $12.08.
How far are Niagen Bioscience's low and high targets from the recorded price?
The low target implies +168.1%, while the high target implies +594%.
How many analysts are included in Niagen Bioscience's consensus?
The verified consensus includes 6 analysts.
How is Niagen Bioscience's target upside or downside calculated?
The average target of $12.08 is divided by the recorded price of $3.17, then one is subtracted to produce +281.2%. This does not guarantee a future return.
When was Niagen Bioscience's analyst forecast verified?
The data was verified on 2026-09-03. The dataset is valid through 2026-09-10.